Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
The MS Center for Innovation in Care
mi
from
St. Louis, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
The MS Center for Innovation in Care
mi
from
St. Louis, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of New Mexico
mi
from
Albuquerque, NM
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of New Mexico
mi
from
Albuquerque, NM
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Island Neurological Associates
mi
from
Plainview, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Island Neurological Associates
mi
from
Plainview, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Toledo Health Science Campus
mi
from
Toledo, OH
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Toledo Health Science Campus
mi
from
Toledo, OH
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
MS Center of Oklahoma
mi
from
Oklahoma City, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
MS Center of Oklahoma
mi
from
Oklahoma City, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Neurological Associates of Tulsa, Inc
mi
from
Tulsa, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Neurological Associates of Tulsa, Inc
mi
from
Tulsa, OK
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Vanderbilt University Medical Center
mi
from
Ventura, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Ventura, CA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Univ of Texas Galveston
mi
from
Galveston, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Univ of Texas Galveston
mi
from
Galveston, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Integra Clinical Research
mi
from
San Antonio, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Integra Clinical Research
mi
from
San Antonio, TX
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Seattle Neuroscience Institute/Swedish Medical, 550 17th Avenue, Suite 500
mi
from
Seattle, WA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Seattle Neuroscience Institute/Swedish Medical, 550 17th Avenue, Suite 500
mi
from
Seattle, WA
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
University of Wisconsin-Madison
mi
from
Madison, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
University of Wisconsin-Madison
mi
from
Madison, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Saint Luke's/ Mid-America Heart Institute
mi
from
Kansas City, MO
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Status: Archived
Updated: 1/1/1970
Saint Luke's/ Mid-America Heart Institute
mi
from
Kansas City, MO
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Uc Irvine Medical Center
mi
from
Orange, CA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Uc Irvine Medical Center
mi
from
Orange, CA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
California Pacific Medical Center
mi
from
San Francisco, CA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
California Pacific Medical Center
mi
from
San Francisco, CA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Kansas Medical Center, Landon Center on Aging
mi
from
Kansas City, KA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Kansas Medical Center, Landon Center on Aging
mi
from
Kansas City, KA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Kentucky Hospital
mi
from
Lexington, KY
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Kentucky Hospital
mi
from
Lexington, KY
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
State University of New York - Erie Country Medical Center
mi
from
Buffalo, NY
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
State University of New York - Erie Country Medical Center
mi
from
Buffalo, NY
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Carolinas Medical Center-Myers Park
mi
from
Charlotte, NC
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Carolinas Medical Center-Myers Park
mi
from
Charlotte, NC
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Duke University Hospital
mi
from
Durham, NC
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Duke University Hospital
mi
from
Durham, NC
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Cleveland Clinic Florida
mi
from
Weston, FL
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Providence ALS Center
mi
from
Portland, OR
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Providence ALS Center
mi
from
Portland, OR
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
The Methodist Hospital Research Institute
mi
from
Houston, TX
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
The Methodist Hospital Research Institute
mi
from
Houston, TX
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Clinical Trial Facility
mi
from
Detroit, MI
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Detroit, MI
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Clinical Trial Facility
mi
from
Medford, OR
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Medford, OR
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
A Randomized, Double-Blind, Placebo-Controlled Ascending Single-Dose Study of the Intravenous Infusion of CNTO 0007 in Subjects Who Have Experienced Ischemic Cerebral Infarction
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Glyburide Advantage in Malignant Edema and Stroke Pilot
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
University of Maryland, Baltimore
mi
from
Baltimore, MD
Glyburide Advantage in Malignant Edema and Stroke Pilot
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Updated: 1/1/1970
University of Maryland, Baltimore
mi
from
Baltimore, MD
Glyburide Advantage in Malignant Edema and Stroke Pilot
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Glyburide Advantage in Malignant Edema and Stroke Pilot
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Maryann Lehmann, D.D.S.
mi
from
Darien, CT
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Maryann Lehmann, D.D.S.
mi
from
Darien, CT
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Oracare Research
mi
from
Sanford, FL
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Oracare Research
mi
from
Sanford, FL
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Small Smiles Dental Center of Springfield, LLC
mi
from
Springfield, MA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Small Smiles Dental Center of Springfield, LLC
mi
from
Springfield, MA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Bordentown Family Dental
mi
from
Bordentown, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Bordentown Family Dental
mi
from
Bordentown, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Scott B Schaffer, DMD
mi
from
Clark, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Scott B Schaffer, DMD
mi
from
Clark, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Gentle Dental Care, LLC
mi
from
Edison, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Gentle Dental Care, LLC
mi
from
Edison, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Cynthia Jetter, DMD
mi
from
Voorhees, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Cynthia Jetter, DMD
mi
from
Voorhees, NJ
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Bay Dental PC
mi
from
Brooklyn, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Bay Dental PC
mi
from
Brooklyn, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Queens Comprehensive Dental Services
mi
from
Forest Hills, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Queens Comprehensive Dental Services
mi
from
Forest Hills, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Kay T. Oen, DDS
mi
from
Port Chester, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Kay T. Oen, DDS
mi
from
Port Chester, NY